🇺🇸 FDA
Pipeline program

TQB3616 capsules

TQB3616-II-01

Phase 2 small_molecule completed

Quick answer

TQB3616 capsules for HR-positive, HER2-negative Advanced Breast Cancer is a Phase 2 program (small_molecule) at Chia Tai Tianqing Pharmaceutical Group Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Chia Tai Tianqing Pharmaceutical Group Co.,
Indication
HR-positive, HER2-negative Advanced Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials